PD 160170 is a compound developed to inhibit low-risk myelodysplastic syndrome-associated anemia with activities that promote red blood cell transfusion independence and increase hemoglobin.
Molecular Weight:
371.41
CAS Number:
[181468-88-2]
Formula:
C18H17N3O4S
Target:
Neuropeptide Y Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted